{
  "id": "5c65901c7c78d69471000008",
  "type": "factoid",
  "question": "Which disease is PGT121 used for?",
  "ideal_answer": "The broadly neutrilizing antibody PGT121 is being tested against HIV-1.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/29321310"
  ],
  "snippets": [
    {
      "text": "We investigated adenovirus serotype 5 (Ad5) and adeno-associated virus serotype 1 (AAV1) vectors to deliver the HIV-1-specific bNAb PGT121 in wild-type and immunocompromised C57BL/6 mice as well as in HIV-1-infected bone marrow-liver-thymus (BLT) humanized mice.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29321310",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In HIV-1-infected BLT humanized mice, Ad5.PGT121 resulted in a greater reduction of viral loads than did AAV1.PGT121. Ad5.PGT121 also led to more-sustained virologic control than purified PGT121 IgG. Ad5.PGT121 afforded more rapid, robust, and durable antiviral efficacy than AAV1.PGT121 and purified PGT121 IgG in HIV-1-infected humanized mice. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29321310",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We investigated adenovirus serotype 5 (Ad5) and adeno-associated virus serotype 1 (AAV1) vectors to deliver the HIV-1-specific bNAb PGT121. Ad5.PGT121 afforded more rapid, robust, and durable antiviral efficacy than AAV1.PGT121 and purified PGT121 IgG in HIV-1-infected humanized mice.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29321310",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "HIV, AIDS"
}